Our findings are consistent with work involving convalescent COVID-19 patients showing evidence of trained immunity and persisting chromatin remodeling in myeloid and lymphoid cell populations involving high levels of activity of AP-1 transcription factors (You et al., 2021). This evidence concerns the gene JUN and COVID-19.